Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical evaluation of molecularly targeted therapy with temsirolimus in metastatic renal cell carcinoma (PETTO)
2008-003328-45Phase 2Completed
- Sponsor
- Sahlgrenska University Hospital
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of temsirolimus in metastatic renal cell carcinoma (mRCC), sponsored by Sahlgrenska University Hospital. Primary endpoint: Change in FDG uptake after one month of temsirolimus compared to baseline. Started Jul 2008; status: completed.
02
Drugs
temsirolimus
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on 2008-003328-45.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003328-45.